Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.24.1.1.u2
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 7,389 $ 6,071
Short-term investments 10,825 17,859
Income taxes receivable   38
Prepaid expenses and other current assets 840 1,628
Total current assets 19,054 25,596
Property and equipment, net 44 51
Restricted cash 34 34
Other assets 493 578
Total assets 19,625 26,259
Current liabilities:    
Accounts payable 2,966 4,996
Accrued expenses 1,859 7,761
Exchangeable Notes 12,203  
Other current liabilities 755 761
Income taxes payable 11  
Total current liabilities 17,794 13,518
Exchangeable Notes   11,453
Royalty-linked notes 7,889 7,503
Other liabilities 92 188
Total liabilities 25,775 32,662
Commitments and contingencies (Note 14)
Shareholders' deficit    
Undesignated preferred shares, $0.01 par value per share: 100,000,000 shares authorized at March 31, 2024 and December 31, 2023; no shares issued at March 31, 2024 and December 31, 2023
Ordinary shares, $0.01 par value per share: 80,000,000 shares authorized at March 31, 2024 and December 31, 2023, 16,470,414 shares issued at March 31, 2024; 13,499,003 shares issued at December 31, 2023 165 135
Additional paid-in capital 462,084 454,759
Accumulated deficit (468,399) (461,298)
Accumulated other comprehensive income   1
Total shareholders' deficit (6,150) (6,403)
Total liabilities and shareholders' deficit $ 19,625 $ 26,259